Generation Bio Co.
GBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $19,892 | $5,904 | $0 | $0 |
| % Growth | 236.9% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $19,892 | $5,904 | $0 | $0 |
| % Margin | 100% | 100% | – | – |
| R&D Expenses | $61,305 | $93,617 | $96,718 | $85,247 |
| G&A Expenses | $37,780 | $50,850 | $44,464 | $33,854 |
| SG&A Expenses | $37,780 | $50,850 | $44,464 | $33,854 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $63,197 | $0 | $0 | $0 |
| Operating Expenses | $162,282 | $144,467 | $141,182 | $119,101 |
| Operating Income | -$142,390 | -$138,563 | -$141,182 | -$119,101 |
| % Margin | -715.8% | -2,346.9% | – | – |
| Other Income/Exp. Net | $10,722 | $11,951 | $4,543 | -$50 |
| Pre-Tax Income | -$131,668 | -$126,612 | -$136,639 | -$119,151 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$131,668 | -$126,612 | -$136,639 | -$119,151 |
| % Margin | -661.9% | -2,144.5% | – | – |
| EPS | -19.76 | -19.63 | -23.51 | -21.17 |
| % Growth | -0.7% | 16.5% | -11.1% | – |
| EPS Diluted | -19.76 | -19.63 | -23.51 | -21.17 |
| Weighted Avg Shares Out | 6,662 | 6,448 | 5,811 | 5,630 |
| Weighted Avg Shares Out Dil | 6,662 | 6,448 | 5,811 | 5,630 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10,722 | $11,951 | $4,543 | $187 |
| Interest Expense | $0 | $0 | $4,543 | $50 |
| Depreciation & Amortization | $4,931 | $5,263 | $5,130 | $4,532 |
| EBITDA | -$74,262 | -$133,300 | -$136,052 | -$114,569 |
| % Margin | -373.3% | -2,257.8% | – | – |